253 related articles for article (PubMed ID: 20642268)
1. Treating diabetic peripheral neuropathic pain.
Lindsay TJ; Rodgers BC; Savath V; Hettinger K
Am Fam Physician; 2010 Jul; 82(2):151-8. PubMed ID: 20642268
[TBL] [Abstract][Full Text] [Related]
2. Safety profile of treatment in diabetic peripheral neuropathic pain.
Robinson-Papp J; Simpson DM
Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D
Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449
[TBL] [Abstract][Full Text] [Related]
4. Clinical inquiry: what medications are best for diabetic neuropathic pain?
Page N; Deluca J; Crowell K
J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
6. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
Beard SM; McCrink L; Le TK; Garcia-Cebrian A; Monz B; Malik RA
Curr Med Res Opin; 2008 Feb; 24(2):385-99. PubMed ID: 18157921
[TBL] [Abstract][Full Text] [Related]
8. [DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS].
Kiss G
Ideggyogy Sz; 2015 Mar; 68(3-4):93-8. PubMed ID: 26434196
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
[TBL] [Abstract][Full Text] [Related]
10. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Yang M; Qian C; Liu Y
Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y
J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
Terneus W
J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
[TBL] [Abstract][Full Text] [Related]
14. Update on pharmacotherapy guidelines for treatment of neuropathic pain.
Wallace JM
Curr Pain Headache Rep; 2007 Jun; 11(3):208-14. PubMed ID: 17504648
[TBL] [Abstract][Full Text] [Related]
15. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
[TBL] [Abstract][Full Text] [Related]
16. Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy.
Wu JJ; Fleming KF
Cutis; 2011 May; 87(5):249-50. PubMed ID: 21699129
[No Abstract] [Full Text] [Related]
17. A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin.
Spiegel DR; Lappinen E; Gottlieb M
Gen Hosp Psychiatry; 2010; 32(2):228.e5-7. PubMed ID: 20303003
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
[TBL] [Abstract][Full Text] [Related]
20. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
Zhao Y; Sun P; Watson P
Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
